screen
metalloproteas
librari
led
identif
thiolbas
dual
acenep
inhibitor
potent
inhibitor
modif
p
benzyl
moieti
led
improv
potenc
well
increas
select
versu
ace
nep
process
angiotensin
receptor
agonist
angiotensin
ii
produc
angiotensin
ma
receptor
agonist
angiotensin
respect
exact
role
reninangiotensin
system
ra
need
clarifi
one
group
report
mice
exhibit
sever
reduct
cardiac
contractil
rescu
ace
doubl
knockout
contrast
anoth
group
disclos
mice
mix
background
exhibit
cardiac
contractil
defect
increas
suscept
angiotensin
iiinduc
hypertens
third
group
reveal
male
ace
mice
suscept
heart
failur
death
transvers
aortic
constrict
normal
litterm
support
role
cardiac
function
transgen
mice
overexpress
heart
lower
mean
arteri
pressur
rare
focal
myocyt
vacuol
myofibril
splay
nuclear
enlarg
mani
mice
develop
termin
ventricular
fibril
lethal
arrhythmia
furthermor
male
mice
femal
mice
also
accumul
fibrillar
collagen
renal
glomerular
mesangium
lead
develop
glomerulosclerosi
kidney
addit
mice
exhibit
lower
bodi
weight
wild
type
mice
reduc
fat
mass
moreov
also
util
sever
acut
respiratori
syndrom
sar
coronaviru
receptor
infect
mice
resist
sar
corona
viru
infect
final
mice
enhanc
vascular
permeabl
increas
lung
edema
worsen
lung
function
sever
murin
acut
respiratori
distress
syndrom
ard
model
mani
potenti
function
small
molecul
inhibitor
enzym
could
util
help
defin
physiolog
role
proteas
belong
zinc
metalloproteas
famili
report
classic
ace
inhibitor
captopril
lisinopril
attenu
enzym
activ
part
strategi
discov
lead
molecul
inhibitor
program
direct
screen
versu
set
metalloproteas
inhibitor
glaxosmithklin
compound
collect
perform
surprisingli
although
confirm
classic
ace
inhibitor
like
captopril
inact
screen
thiol
acid
identifi
potent
inhibitor
k
app
nm
biphenyl
analog
known
dual
ace
metalloproteas
neutral
endopeptidas
neprilysin
nep
ec
inhibitor
ace
k
app
nm
nep
k
app
nm
also
inhibit
metalloproteas
carboxypeptidas
cpa
ec
k
app
nm
specul
thiol
function
bind
group
activ
site
zinc
carboxyl
acid
serv
recognit
element
enzym
monocarboxypeptidas
activ
benzyl
methylen
pbiphenyl
moieti
surmis
p
p
substitu
premis
structur
activ
relationship
p
posit
lead
inhibitor
explor
goal
improv
potenc
reduc
ace
nep
inhibitori
activ
thiol
analog
prepar
depict
scheme
acid
activ
situ
via
carbodiimid
convert
activ
ester
azahydroxybenzotriazol
coupl
amin
hydrochlorid
produc
fulli
protect
amid
subsequ
hydrolysi
methyl
ester
well
thioacet
lithium
hydroxid
afford
thiol
acid
thiol
acid
produc
three
differ
rout
acid
prepar
reaction
commerci
avail
thiol
x
acetyl
chlorid
contrast
acid
produc
alcohol
x
via
mitsunobu
reaction
thioacet
acid
altern
acid
synthes
commerci
avail
amino
acid
x
nh
diazot
amin
afford
bromid
subsequ
displac
bromid
potassium
thioacet
stereochem
invers
stereochem
eros
presum
result
format
alacton
nucleophil
trap
result
mitsunobu
diazot
reaction
step
coupl
amin
minor
diastereom
could
remov
via
chromatographi
structureact
relationship
p
analog
depict
tabl
r
isom
deriv
l
lphenylalanin
display
p
benzyl
substitu
unnatur
configur
orient
p
substitu
detriment
inhibitori
activ
diastereom
k
app
nm
well
ace
k
app
nm
loss
inhibit
surpris
sinc
natur
evolv
proteas
recogn
natur
configur
physiolog
peptid
substrat
contrast
nep
k
app
nm
accommod
altern
configur
loss
potenc
complet
remov
p
moieti
caus
modest
loss
inhibitori
potenc
versu
h
k
app
nm
decreas
potenc
could
aris
reduc
van
der
waal
interact
due
lack
p
substitu
increas
entrop
cost
inhibitor
bind
proteas
given
inhibitor
increas
rotat
freedom
combin
factor
contrast
disom
ace
activ
k
app
nm
glycinelik
analog
affect
elimin
p
element
nep
potenc
k
app
nm
decreas
order
magnitud
alaninederiv
analog
k
app
nm
decreas
rotat
freedom
even
potent
inhibitor
start
lead
increas
select
versu
ace
k
app
nm
nep
k
app
nm
contrast
gemin
dimethyl
analog
k
app
nm
decreas
inhibitori
potenc
versu
also
ace
k
app
nm
nep
k
app
nm
similar
methyl
analog
linear
p
ethyl
nbutyl
analog
et
k
app
nm
nbu
k
app
nm
also
potent
inhibitor
extens
p
also
increas
activ
versu
ace
k
app
nm
k
app
nm
even
versu
nep
k
app
nm
k
app
nm
hope
improv
select
thiolbas
inhibitor
versu
ace
nep
effect
branch
along
p
side
chain
inhibitor
class
explor
branch
along
p
chain
well
toler
subsit
abranch
isopropyl
ipr
k
app
neopentyl
ch
tbu
k
app
nm
analog
maintain
inhibit
bulkier
branch
analog
like
abranch
cyclohexyl
cyh
k
app
nm
phenyl
ph
k
app
nm
bbranch
methylen
cyclohexyl
ch
cyh
k
app
nm
methylen
bnaphthyl
ch
bnp
k
app
nm
cbranch
ethylen
phenyl
ch
ph
k
app
nm
larg
accommod
subsit
contrast
abranch
p
moieti
poorli
toler
ace
subsit
result
substanti
decreas
ace
inhibitori
activ
abranch
isopropyl
k
app
nm
r
secbutyl
k
app
nm
secbutyl
k
app
nm
cyclobutyl
k
app
nm
cyclopentyl
k
app
nm
cyclohexyl
k
app
nm
phenyl
k
app
nm
analog
subsit
nep
accept
abranch
p
substitu
ace
enzym
less
liber
abranch
isopropyl
k
app
nm
r
secbutyl
k
app
nm
secbutyl
k
app
nm
cyclobutyl
k
app
nm
cyclopentyl
k
app
nm
cyclohexyl
k
app
nm
phenyl
k
app
nm
analog
lost
inhibitori
activ
versu
nep
rel
ethyl
analog
k
app
nm
thu
abranch
p
group
enhanc
select
proteas
inhibit
rel
ace
nep
r
secbutyl
analog
k
app
nm
select
versu
ace
select
versu
nep
cyclopentyl
k
app
nm
select
versu
ace
select
versu
nep
comparison
abranch
ace
nep
subsit
permiss
bbranch
p
group
thu
isobutyl
analog
potent
inhibitor
k
app
nm
also
low
nanomolar
ace
k
app
nm
subnanomolar
nep
inhibitor
k
app
nm
ace
less
toler
bulki
bbranch
neopentyl
analog
exhibit
potent
dual
k
app
nm
nep
k
app
nm
inhibit
good
select
ace
k
app
nm
larger
bbranch
substitu
like
methylen
cyclohexyl
k
app
nm
ace
k
app
nm
nep
k
app
nm
methylen
bnaphthyl
k
app
nm
ace
k
app
nm
nep
k
app
nm
attenu
inhibitori
activ
three
enzym
final
ethylen
phenyl
analog
show
like
k
app
nm
ace
k
app
nm
less
toler
cbranch
p
group
nep
k
app
nm
accept
none
thiolbas
inhibitor
potent
inhibitor
cpa
model
thiol
dock
activ
site
base
recent
xray
crystal
structur
shown
figur
provid
insight
sar
thiol
seri
addit
bind
imidazol
nitrogen
carboxyl
glu
activ
site
zinc
coordin
thiol
inhibitor
also
termin
carboxyl
inhibitor
form
electrostat
interact
guanidin
arg
accept
hydrogen
bond
imidazol
moreov
carbonyl
pro
accept
hydrogen
bond
amid
nitrogen
inhibitor
amid
carbonyl
stabil
hydrogen
bond
tyr
furthermor
p
methylen
biphenyl
substitu
form
signific
lipophil
interact
quit
larg
channel
compos
lengthwis
canal
two
subdomain
includ
residu
phe
thr
pro
asp
leu
thr
biphenyl
substitu
hypothes
occupi
differ
part
larg
pocket
carboxyl
inhibitor
cocrystal
p
r
secbutyl
group
inhibitor
form
van
der
waal
interact
pocket
compos
thr
phe
tyr
arg
shown
closeup
subsit
depict
figur
tyr
form
part
pocket
abranch
methyl
p
r
secbutyl
group
occupi
larger
substitu
disfavor
would
requir
movement
phenol
side
chain
tyr
thu
model
agre
sar
sinc
subsit
toler
cyclobutyl
cyclopentyl
substitu
less
accept
cyclohexyl
group
model
inhibitor
dock
activ
site
ace
focus
subsit
base
xray
structur
lisinopril
ace
shown
figur
model
appar
methyl
group
r
secbutyl
p
moieti
inhibitor
bump
enzym
help
explain
select
versu
ace
branch
natur
val
atom
make
portion
pocket
smaller
val
homolog
residu
ace
tyr
tyr
val
substitut
ace
result
alter
pocket
volum
help
explain
reduc
abil
ace
accommod
abranch
p
substitu
although
xray
structur
nep
cocrystal
thiolbas
inhibitor
pdb
code
analog
p
biphenyl
moieti
pdb
code
avail
nep
belong
differ
metalloproteas
famili
vs
reason
model
thiol
inhibitor
bound
nep
could
determin
help
explain
increas
nep
select
abranch
p
analog
like
protein
movement
accommod
potent
nep
inhibitor
like
requir
movement
multipl
amino
acid
residu
protein
difficult
predict
accur
summari
seri
athiol
amidebas
inhibitor
vari
substitu
p
posit
synthes
inhibitor
contain
linear
alkyl
p
moieti
potent
analog
enzymat
assay
smaller
abranch
p
substitu
exemplifi
inhibitor
maintain
similar
potenc
increas
select
versu
ace
nep
inform
gain
studi
proven
use
design
inhibitor
inhibitor
report
due
cours
furthermor
potent
pan
inhibitor
potent
dual
inhibitor
identifi
tool
may
prove
use
defin
role
proteas
play
ra
cascad
hydrolys
carri
reaction
open
atmospher
vari
amount
disulfid
product
isol
like
aerob
oxid
enzym
assay
contain
reduc
agent
tri
phosphat
tcep
prevent
oxid
thiol
disulfid
assay
dilut
mm
stock
solut
thiol
final
assay
concentr
done
aqueou
acetonitril
prior
proteas
inhibit
studi
standard
condit
thiol
correspond
disulfid
show
enzym
inhibitori
activ
presum
disulfid
reduc
correspond
thiol
tcep
preincub
period
substrat
ad
contrast
assay
perform
without
tcep
disulfid
complet
inact
potenc
thiol
attenu
probabl
partial
aerob
oxid
correspond
disulfid
preincub
period
alcohol
commerci
avail
alcohol
prepar
cyclobutan
methanol
three
step
first
oxid
alcohol
pyridinium
chlorochrom
afford
aldehyd
reaction
aldehyd
trimethylsilyl
cyanid
nmethyl
morpholin
noxid
provid
silyl
protect
cyano
